NPPA issues an analysis showing that private hospitals are hugely overcharging patients

Feb 23, 2018 | by Avantis RegTech Legal Research Team

A |  A

National Pharmaceutical Pricing Authority (NPPA) vide Office Memorandum dated February 20, 2018, has issued an analysis regarding overpricing and inflated bills from families of some patients who lost their lives particularly due to dengue. The NPPA has observed that hospitals have been overcharging patients for drugs, medical tests and consumable items.

The Authority has identified the strategy used by hospitals for inflating medical bills, by prescribing non-scheduled branded drugs which do not fall under price control, in spite of the fact that all essential medicines are listed under the National List of Essential Medicines 2015. NPPA has also suggested the need of a policy intervention to tackle this situation, thus, leading to the rate of growth of non-NLEM drugs which had reached double the rate of NLEM drugs in the year 2017.

[File No. 27(2)/ 2017-Div-lll/NPPA]




Related Updates

Alternate Text

Get updates on the go on RuleZbook Mobile App.